# Dianthus Therapeutics, Inc.: filings

DNTH · Nasdaq · CIK 1690585 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dnth.md) · [Financials](/companies/dnth/financials.md) · [Filings](/companies/dnth/filings.md) · [Insiders](/companies/dnth/insiders.md)

## Reports and events: 152 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 242, 8-K 87, 3 43, 10-Q 25, SCHEDULE 13G/A 24, SC 13G/A 23, 144 21, SC 13G 19, CORRESP 18, UPLOAD 14, S-8 11, EFFECT 10, 424B5 9, SCHEDULE 13G 9, 10-K 8, 424B3 7, DEF 14A 7, DEFA14A 7, S-3 7, SC 13D/A 7, S-1/A 6, CT ORDER 4, SC 13D 4, SCHEDULE 13D/A 4, 425 3, 8-A12B 3, ARS 3, D 3, S-4/A 3, 424B4 2, 4/A 2, DRS 2, S-1 2, 10-K/A 1, 3/A 1, 5 1, 8-K/A 1, CERT 1, DRS/A 1, DRSLTR 1, FWP 1, RW 1, S-3ASR 1, S-3MEF 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:08 ET | [10-Q](/filings/0001690585-26-000034.md) | Quarterly report, period 2026-06-30 | 0001690585-26-000034 |
| 2026-08-04 | 16:05 ET | [8-K](/filings/0001690585-26-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001690585-26-000033 |
| 2026-06-12 | 07:00 ET | [8-K](/filings/0001690585-26-000029.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001690585-26-000029 |
| 2026-05-22 | 16:10 ET | [8-K](/filings/0001690585-26-000026.md) | 5.07 Shareholder vote results | 0001690585-26-000026 |
| 2026-05-05 | 16:06 ET | [10-Q](/filings/0001690585-26-000022.md) | Quarterly report, period 2026-03-31 | 0001690585-26-000022 |
| 2026-05-05 | 16:03 ET | [8-K](/filings/0001690585-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001690585-26-000021 |
| 2026-04-09 | 16:09 ET | [DEF 14A](/filings/0001690585-26-000012.md) | Proxy statement, period 2026-05-21 | 0001690585-26-000012 |
| 2026-03-26 | 08:00 ET | [8-K](/filings/0001690585-26-000010.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001690585-26-000010 |
| 2026-03-12 | 07:20 ET | [8-K](/filings/0001193125-26-103053.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-103053 |
| 2026-03-09 | 07:21 ET | [10-K](/filings/0001690585-26-000006.md) | Annual report, period 2025-12-31 | 0001690585-26-000006 |
| 2026-03-09 | 07:19 ET | [8-K](/filings/0001193125-26-097555.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-097555 |
| 2026-01-12 | 09:01 ET | [8-K](/filings/0001193125-26-009898.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009898 |
| 2025-11-25 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001104659-25-116119.md) | Ownership report, active investor, amended | 0001104659-25-116119 |
| 2025-11-19 | 21:15 ET | [SCHEDULE 13D/A](/filings/0000919574-25-007115.md) | Ownership report, active investor, amended | 0000919574-25-007115 |
| 2025-11-05 | 16:09 ET | [10-Q](/filings/0001193125-25-266920.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266920 |
| 2025-11-05 | 16:03 ET | [8-K](/filings/0001193125-25-266867.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266867 |
| 2025-11-03 | 13:04 ET | [8-K](/filings/0001193125-25-262188.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-262188 |
| 2025-10-16 | 08:00 ET | [8-K](/filings/0001193125-25-240858.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-240858 |
| 2025-09-15 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-25-090015.md) | Ownership report, active investor, amended | 0001104659-25-090015 |
| 2025-09-11 | 07:20 ET | [8-K](/filings/0001193125-25-200715.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-200715 |
| 2025-09-08 | 08:01 ET | [8-K](/filings/0001193125-25-197751.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-197751 |
| 2025-08-07 | 16:11 ET | [10-Q](/filings/0000950170-25-105030.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105030 |
| 2025-08-07 | 16:07 ET | [8-K](/filings/0000950170-25-105002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105002 |
| 2025-05-22 | 16:05 ET | [8-K](/filings/0000950170-25-076304.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-076304 |
| 2025-05-12 | 16:14 ET | [10-Q](/filings/0000950170-25-069226.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069226 |
| 2025-05-12 | 16:10 ET | [8-K](/filings/0000950170-25-069195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069195 |
| 2025-04-10 | 16:31 ET | [DEF 14A](/filings/0000950170-25-052874.md) | Proxy statement, period 2025-05-22 | 0000950170-25-052874 |
| 2025-03-19 | 21:30 ET | [SCHEDULE 13D/A](/filings/0000919574-25-002011.md) | Ownership report, active investor, amended | 0000919574-25-002011 |
| 2025-03-11 | 16:06 ET | [10-K](/filings/0000950170-25-037131.md) | Annual report, period 2024-12-31 | 0000950170-25-037131 |
| 2025-03-11 | 16:03 ET | [8-K](/filings/0000950170-25-037125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-037125 |
| 2025-03-05 | 07:16 ET | [8-K](/filings/0000950170-25-033075.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-033075 |
| 2024-12-12 | 16:06 ET | [8-K](/filings/0000950170-24-135775.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135775 |
| 2024-12-03 | 21:19 ET | [SC 13D/A](/filings/0000919574-24-006998.md) | Ownership report, active investor, amended | 0000919574-24-006998 |
| 2024-11-07 | 16:05 ET | [10-Q](/filings/0000950170-24-123285.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123285 |
| 2024-11-07 | 16:03 ET | [8-K](/filings/0000950170-24-123255.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123255 |
| 2024-09-16 | 16:06 ET | [8-K](/filings/0000950170-24-106820.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-106820 |
| 2024-09-12 | 20:45 ET | [SC 13D/A](/filings/0001104659-24-099432.md) | Ownership report, active investor, amended | 0001104659-24-099432 |
| 2024-08-08 | 16:10 ET | [10-Q](/filings/0000950170-24-093948.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093948 |
| 2024-08-08 | 16:06 ET | [8-K](/filings/0000950170-24-093920.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093920 |
| 2024-06-06 | 08:00 ET | [8-K](/filings/0000950170-24-069675.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-069675 |
| 2024-05-28 | 17:20 ET | [8-K](/filings/0000950170-24-065371.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-065371 |
| 2024-05-09 | 16:20 ET | [10-Q](/filings/0000950170-24-057022.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057022 |
| 2024-05-09 | 16:08 ET | [8-K](/filings/0000950170-24-056925.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056925 |
| 2024-04-11 | 16:05 ET | [DEF 14A](/filings/0000950170-24-043693.md) | Proxy statement, period 2024-05-23 | 0000950170-24-043693 |
| 2024-04-01 | 18:34 ET | [SC 13D/A](/filings/0001193125-24-083707.md) | Ownership report, active investor, amended | 0001193125-24-083707 |
| 2024-03-21 | 17:02 ET | [S-1/A](/filings/0001193125-24-073956.md) | Registration statement, amended | 0001193125-24-073956 |
| 2024-03-21 | 16:07 ET | [10-K](/filings/0000950170-24-034681.md) | Annual report, period 2023-12-31 | 0000950170-24-034681 |
| 2024-03-21 | 16:04 ET | [8-K](/filings/0000950170-24-034667.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034667 |
| 2024-02-07 | 16:52 ET | [S-1/A](/filings/0001193125-24-026760.md) | Registration statement, amended | 0001193125-24-026760 |
| 2024-01-31 | 12:11 ET | [SC 13D](/filings/0000919574-24-000598.md) | Ownership report, active investor | 0000919574-24-000598 |

Page 1 of 4. [Older](/companies/dnth/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:27 ET. No prices; not investment advice.